Analgesic Effect of Switching From Oral Opioids to a Once-a-Day Fentanyl Citrate Transdermal Patch in Patients With Lung Cancer

A new once-a-day fentanyl citrate transdermal patch was developed in Japan. We retrospectively investigated analgesic and adverse effects of this drug in 24 patients with lung cancer. All patients were started on this patch by switching from an oral opioid. The mean pain score before switching was 2...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:American journal of hospice & palliative medicine 2013-11, Vol.30 (7), p.726-729
Hauptverfasser: Takakuwa, Osamu, Oguri, Tetsuya, Maeno, Ken, Yokoyama, Midori, Hijikata, Hisatoshi, Uemura, Takehiro, Ozasa, Hiroaki, Ohkubo, Hirotsugu, Miyazaki, Mikinori, Niimi, Akio
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 729
container_issue 7
container_start_page 726
container_title American journal of hospice & palliative medicine
container_volume 30
creator Takakuwa, Osamu
Oguri, Tetsuya
Maeno, Ken
Yokoyama, Midori
Hijikata, Hisatoshi
Uemura, Takehiro
Ozasa, Hiroaki
Ohkubo, Hirotsugu
Miyazaki, Mikinori
Niimi, Akio
description A new once-a-day fentanyl citrate transdermal patch was developed in Japan. We retrospectively investigated analgesic and adverse effects of this drug in 24 patients with lung cancer. All patients were started on this patch by switching from an oral opioid. The mean pain score before switching was 2.45 (0-5); 48 hours after switching, 15 of the 24 patients showed a decreased pain score and the mean score (2.00) was significantly lower than that before switching. Of the 16 patients who had adverse effects of oral opioids, 7 patients showed improvement in their symptoms after switching. Two patients showed adverse effects of the drug but their symptoms were mild, and no patient required dose decrease. This new transdermal patch could be a useful treatment option for cancer pain.
doi_str_mv 10.1177/1049909112470020
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_1443413321</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sage_id>10.1177_1049909112470020</sage_id><sourcerecordid>1443413321</sourcerecordid><originalsourceid>FETCH-LOGICAL-c337t-c43c6a6d813fcf9e446b855503b11992fbfc5d892b28a398273747320536277b3</originalsourceid><addsrcrecordid>eNp1kDtLBDEUhYMovnsrSWkzmptkJpNS1l0VFlZQsRwymWSNzGNNMshW_nWzrFoIVvfA_c5XHITOgFwCCHEFhEtJJADlghBKdtAhSFZmVEC-m3J6Z5v_AToK4Y0QRjmHfXRAGS14UcAh-rzuVbs0wWk8tdboiAeLHz9c1K-uX-KZHzq88KrFi5UbXBNwHLDCi16bTGU3ao1npo-qX7d44qJX0eAnr_rQGN-l0oNKHuz6TXAJDPjFxVc8H5N6opLEn6A9q9pgTr_vMXqeTZ8md9l8cXs_uZ5nmjERM82ZLlTRlMCsttJwXtRlnueE1QBSUltbnTelpDUtFZMlFUxwwSjJWUGFqNkxuth6V354H02IVeeCNm2rejOMoQLOGQfGKCSUbFHthxC8sdXKu075dQWk2sxe_Z09Vc6_7WPdmea38LNzArItENTSVG_D6NPs4X_hFwniiC0</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1443413321</pqid></control><display><type>article</type><title>Analgesic Effect of Switching From Oral Opioids to a Once-a-Day Fentanyl Citrate Transdermal Patch in Patients With Lung Cancer</title><source>Access via SAGE</source><source>MEDLINE</source><creator>Takakuwa, Osamu ; Oguri, Tetsuya ; Maeno, Ken ; Yokoyama, Midori ; Hijikata, Hisatoshi ; Uemura, Takehiro ; Ozasa, Hiroaki ; Ohkubo, Hirotsugu ; Miyazaki, Mikinori ; Niimi, Akio</creator><creatorcontrib>Takakuwa, Osamu ; Oguri, Tetsuya ; Maeno, Ken ; Yokoyama, Midori ; Hijikata, Hisatoshi ; Uemura, Takehiro ; Ozasa, Hiroaki ; Ohkubo, Hirotsugu ; Miyazaki, Mikinori ; Niimi, Akio</creatorcontrib><description>A new once-a-day fentanyl citrate transdermal patch was developed in Japan. We retrospectively investigated analgesic and adverse effects of this drug in 24 patients with lung cancer. All patients were started on this patch by switching from an oral opioid. The mean pain score before switching was 2.45 (0-5); 48 hours after switching, 15 of the 24 patients showed a decreased pain score and the mean score (2.00) was significantly lower than that before switching. Of the 16 patients who had adverse effects of oral opioids, 7 patients showed improvement in their symptoms after switching. Two patients showed adverse effects of the drug but their symptoms were mild, and no patient required dose decrease. This new transdermal patch could be a useful treatment option for cancer pain.</description><identifier>ISSN: 1049-9091</identifier><identifier>EISSN: 1938-2715</identifier><identifier>DOI: 10.1177/1049909112470020</identifier><identifier>PMID: 23264661</identifier><language>eng</language><publisher>Los Angeles, CA: SAGE Publications</publisher><subject>Administration, Cutaneous ; Analgesics, Opioid - therapeutic use ; Citric Acid ; Fentanyl - therapeutic use ; Humans ; Lung Neoplasms ; Neoplasms - drug therapy ; Nursing ; Pain - drug therapy ; Transdermal Patch</subject><ispartof>American journal of hospice &amp; palliative medicine, 2013-11, Vol.30 (7), p.726-729</ispartof><rights>The Author(s) 2012</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c337t-c43c6a6d813fcf9e446b855503b11992fbfc5d892b28a398273747320536277b3</citedby><cites>FETCH-LOGICAL-c337t-c43c6a6d813fcf9e446b855503b11992fbfc5d892b28a398273747320536277b3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://journals.sagepub.com/doi/pdf/10.1177/1049909112470020$$EPDF$$P50$$Gsage$$H</linktopdf><linktohtml>$$Uhttps://journals.sagepub.com/doi/10.1177/1049909112470020$$EHTML$$P50$$Gsage$$H</linktohtml><link.rule.ids>314,780,784,21819,27924,27925,43621,43622</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/23264661$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Takakuwa, Osamu</creatorcontrib><creatorcontrib>Oguri, Tetsuya</creatorcontrib><creatorcontrib>Maeno, Ken</creatorcontrib><creatorcontrib>Yokoyama, Midori</creatorcontrib><creatorcontrib>Hijikata, Hisatoshi</creatorcontrib><creatorcontrib>Uemura, Takehiro</creatorcontrib><creatorcontrib>Ozasa, Hiroaki</creatorcontrib><creatorcontrib>Ohkubo, Hirotsugu</creatorcontrib><creatorcontrib>Miyazaki, Mikinori</creatorcontrib><creatorcontrib>Niimi, Akio</creatorcontrib><title>Analgesic Effect of Switching From Oral Opioids to a Once-a-Day Fentanyl Citrate Transdermal Patch in Patients With Lung Cancer</title><title>American journal of hospice &amp; palliative medicine</title><addtitle>Am J Hosp Palliat Care</addtitle><description>A new once-a-day fentanyl citrate transdermal patch was developed in Japan. We retrospectively investigated analgesic and adverse effects of this drug in 24 patients with lung cancer. All patients were started on this patch by switching from an oral opioid. The mean pain score before switching was 2.45 (0-5); 48 hours after switching, 15 of the 24 patients showed a decreased pain score and the mean score (2.00) was significantly lower than that before switching. Of the 16 patients who had adverse effects of oral opioids, 7 patients showed improvement in their symptoms after switching. Two patients showed adverse effects of the drug but their symptoms were mild, and no patient required dose decrease. This new transdermal patch could be a useful treatment option for cancer pain.</description><subject>Administration, Cutaneous</subject><subject>Analgesics, Opioid - therapeutic use</subject><subject>Citric Acid</subject><subject>Fentanyl - therapeutic use</subject><subject>Humans</subject><subject>Lung Neoplasms</subject><subject>Neoplasms - drug therapy</subject><subject>Nursing</subject><subject>Pain - drug therapy</subject><subject>Transdermal Patch</subject><issn>1049-9091</issn><issn>1938-2715</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2013</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp1kDtLBDEUhYMovnsrSWkzmptkJpNS1l0VFlZQsRwymWSNzGNNMshW_nWzrFoIVvfA_c5XHITOgFwCCHEFhEtJJADlghBKdtAhSFZmVEC-m3J6Z5v_AToK4Y0QRjmHfXRAGS14UcAh-rzuVbs0wWk8tdboiAeLHz9c1K-uX-KZHzq88KrFi5UbXBNwHLDCi16bTGU3ao1npo-qX7d44qJX0eAnr_rQGN-l0oNKHuz6TXAJDPjFxVc8H5N6opLEn6A9q9pgTr_vMXqeTZ8md9l8cXs_uZ5nmjERM82ZLlTRlMCsttJwXtRlnueE1QBSUltbnTelpDUtFZMlFUxwwSjJWUGFqNkxuth6V354H02IVeeCNm2rejOMoQLOGQfGKCSUbFHthxC8sdXKu075dQWk2sxe_Z09Vc6_7WPdmea38LNzArItENTSVG_D6NPs4X_hFwniiC0</recordid><startdate>201311</startdate><enddate>201311</enddate><creator>Takakuwa, Osamu</creator><creator>Oguri, Tetsuya</creator><creator>Maeno, Ken</creator><creator>Yokoyama, Midori</creator><creator>Hijikata, Hisatoshi</creator><creator>Uemura, Takehiro</creator><creator>Ozasa, Hiroaki</creator><creator>Ohkubo, Hirotsugu</creator><creator>Miyazaki, Mikinori</creator><creator>Niimi, Akio</creator><general>SAGE Publications</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>201311</creationdate><title>Analgesic Effect of Switching From Oral Opioids to a Once-a-Day Fentanyl Citrate Transdermal Patch in Patients With Lung Cancer</title><author>Takakuwa, Osamu ; Oguri, Tetsuya ; Maeno, Ken ; Yokoyama, Midori ; Hijikata, Hisatoshi ; Uemura, Takehiro ; Ozasa, Hiroaki ; Ohkubo, Hirotsugu ; Miyazaki, Mikinori ; Niimi, Akio</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c337t-c43c6a6d813fcf9e446b855503b11992fbfc5d892b28a398273747320536277b3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2013</creationdate><topic>Administration, Cutaneous</topic><topic>Analgesics, Opioid - therapeutic use</topic><topic>Citric Acid</topic><topic>Fentanyl - therapeutic use</topic><topic>Humans</topic><topic>Lung Neoplasms</topic><topic>Neoplasms - drug therapy</topic><topic>Nursing</topic><topic>Pain - drug therapy</topic><topic>Transdermal Patch</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Takakuwa, Osamu</creatorcontrib><creatorcontrib>Oguri, Tetsuya</creatorcontrib><creatorcontrib>Maeno, Ken</creatorcontrib><creatorcontrib>Yokoyama, Midori</creatorcontrib><creatorcontrib>Hijikata, Hisatoshi</creatorcontrib><creatorcontrib>Uemura, Takehiro</creatorcontrib><creatorcontrib>Ozasa, Hiroaki</creatorcontrib><creatorcontrib>Ohkubo, Hirotsugu</creatorcontrib><creatorcontrib>Miyazaki, Mikinori</creatorcontrib><creatorcontrib>Niimi, Akio</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>American journal of hospice &amp; palliative medicine</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Takakuwa, Osamu</au><au>Oguri, Tetsuya</au><au>Maeno, Ken</au><au>Yokoyama, Midori</au><au>Hijikata, Hisatoshi</au><au>Uemura, Takehiro</au><au>Ozasa, Hiroaki</au><au>Ohkubo, Hirotsugu</au><au>Miyazaki, Mikinori</au><au>Niimi, Akio</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Analgesic Effect of Switching From Oral Opioids to a Once-a-Day Fentanyl Citrate Transdermal Patch in Patients With Lung Cancer</atitle><jtitle>American journal of hospice &amp; palliative medicine</jtitle><addtitle>Am J Hosp Palliat Care</addtitle><date>2013-11</date><risdate>2013</risdate><volume>30</volume><issue>7</issue><spage>726</spage><epage>729</epage><pages>726-729</pages><issn>1049-9091</issn><eissn>1938-2715</eissn><abstract>A new once-a-day fentanyl citrate transdermal patch was developed in Japan. We retrospectively investigated analgesic and adverse effects of this drug in 24 patients with lung cancer. All patients were started on this patch by switching from an oral opioid. The mean pain score before switching was 2.45 (0-5); 48 hours after switching, 15 of the 24 patients showed a decreased pain score and the mean score (2.00) was significantly lower than that before switching. Of the 16 patients who had adverse effects of oral opioids, 7 patients showed improvement in their symptoms after switching. Two patients showed adverse effects of the drug but their symptoms were mild, and no patient required dose decrease. This new transdermal patch could be a useful treatment option for cancer pain.</abstract><cop>Los Angeles, CA</cop><pub>SAGE Publications</pub><pmid>23264661</pmid><doi>10.1177/1049909112470020</doi><tpages>4</tpages></addata></record>
fulltext fulltext
identifier ISSN: 1049-9091
ispartof American journal of hospice & palliative medicine, 2013-11, Vol.30 (7), p.726-729
issn 1049-9091
1938-2715
language eng
recordid cdi_proquest_miscellaneous_1443413321
source Access via SAGE; MEDLINE
subjects Administration, Cutaneous
Analgesics, Opioid - therapeutic use
Citric Acid
Fentanyl - therapeutic use
Humans
Lung Neoplasms
Neoplasms - drug therapy
Nursing
Pain - drug therapy
Transdermal Patch
title Analgesic Effect of Switching From Oral Opioids to a Once-a-Day Fentanyl Citrate Transdermal Patch in Patients With Lung Cancer
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-29T07%3A03%3A34IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Analgesic%20Effect%20of%20Switching%20From%20Oral%20Opioids%20to%20a%20Once-a-Day%20Fentanyl%20Citrate%20Transdermal%20Patch%20in%20Patients%20With%20Lung%20Cancer&rft.jtitle=American%20journal%20of%20hospice%20&%20palliative%20medicine&rft.au=Takakuwa,%20Osamu&rft.date=2013-11&rft.volume=30&rft.issue=7&rft.spage=726&rft.epage=729&rft.pages=726-729&rft.issn=1049-9091&rft.eissn=1938-2715&rft_id=info:doi/10.1177/1049909112470020&rft_dat=%3Cproquest_cross%3E1443413321%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1443413321&rft_id=info:pmid/23264661&rft_sage_id=10.1177_1049909112470020&rfr_iscdi=true